Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics in Tuberculosis
NCT00164463Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jul 2004
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of moxifloxacin in Tuberculosis (TB), sponsored by Centers for Disease Control and Prevention. Started Jul 2004; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00164463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164463.